Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats.

Kohno H, Tanaka T, Kawabata K, Hirose Y, Sugie S, Tsuda H, Mori H.

Int J Cancer. 2002 Oct 10;101(5):461-8.

3.

Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.

Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K, Ohigashi H.

Jpn J Cancer Res. 1997 Sep;88(9):821-30.

PMID:
9369929
4.

Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats.

Kawamori T, Tanaka T, Ohnishi M, Hirose Y, Nakamura Y, Satoh K, Hara A, Mori H.

Cancer Res. 1995 Sep 15;55(18):4053-8.

5.
7.

Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes.

Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K, Ohigashi H.

Cancer Res. 1998 Jun 15;58(12):2550-6.

8.

A bitter diterpenoid furanolactone columbin from Calumbae Radix inhibits azoxymethane-induced rat colon carcinogenesis.

Kohno H, Maeda M, Tanino M, Tsukio Y, Ueda N, Wada K, Sugie S, Mori H, Tanaka T.

Cancer Lett. 2002 Sep 26;183(2):131-9.

PMID:
12065087
9.

Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats.

Kawabata K, Yamamoto T, Hara A, Shimizu M, Yamada Y, Matsunaga K, Tanaka T, Mori H.

Cancer Lett. 2000 Aug 31;157(1):15-21.

PMID:
10893437
10.

Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.

Yanaida Y, Kohno H, Yoshida K, Hirose Y, Yamada Y, Mori H, Tanaka T.

Carcinogenesis. 2002 May;23(5):787-94.

PMID:
12016151
11.

Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone.

Yoshitani SI, Tanaka T, Kohno H, Takashima S.

Int J Oncol. 2001 Nov;19(5):929-39.

PMID:
11604990
13.
14.

Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats.

Kawamori T, Tanaka T, Hirose Y, Satoh K, Hara A, Torihara M, Tamai Y, Yamahara J, Mori H.

Cancer Lett. 1995 Jun 8;92(2):159-65.

PMID:
7600526
15.

Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.

Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS.

Cancer Res. 2001 May 1;61(9):3647-52.

16.

Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin.

Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, Ogawa H.

Carcinogenesis. 1997 May;18(5):957-65.

PMID:
9163681
17.

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.

Cancer Res. 2000 Jan 15;60(2):293-7.

18.

Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate.

Reddy BS, Rivenson A, Kulkarni N, Upadhyaya P, el-Bayoumy K.

Cancer Res. 1992 Oct 15;52(20):5635-40.

19.

Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.

Tanaka T, Shimizu M, Kohno H, Yoshitani S, Tsukio Y, Murakami A, Safitri R, Takahashi D, Yamamoto K, Koshimizu K, Ohigashi H, Mori H.

Life Sci. 2001 Sep 7;69(16):1935-45.

PMID:
11693274
20.

Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence.

Raju J, Swamy MV, Cooma I, Patlolla JM, Pittman B, Reddy BS, Steele VE, Rao CV.

Int J Cancer. 2005 Feb 20;113(5):798-802.

Supplemental Content

Support Center